1. Home
  2. CSBR vs SQNS Comparison

CSBR vs SQNS Comparison

Compare CSBR & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • SQNS
  • Stock Information
  • Founded
  • CSBR 1985
  • SQNS 2003
  • Country
  • CSBR United States
  • SQNS France
  • Employees
  • CSBR N/A
  • SQNS N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • SQNS Semiconductors
  • Sector
  • CSBR Health Care
  • SQNS Technology
  • Exchange
  • CSBR Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • CSBR 123.2M
  • SQNS 140.2M
  • IPO Year
  • CSBR 1986
  • SQNS 2011
  • Fundamental
  • Price
  • CSBR $6.42
  • SQNS $9.79
  • Analyst Decision
  • CSBR Strong Buy
  • SQNS Buy
  • Analyst Count
  • CSBR 1
  • SQNS 1
  • Target Price
  • CSBR $12.00
  • SQNS $35.00
  • AVG Volume (30 Days)
  • CSBR 40.7K
  • SQNS 376.5K
  • Earning Date
  • CSBR 09-15-2025
  • SQNS 11-04-2025
  • Dividend Yield
  • CSBR N/A
  • SQNS N/A
  • EPS Growth
  • CSBR N/A
  • SQNS N/A
  • EPS
  • CSBR 0.21
  • SQNS 18.54
  • Revenue
  • CSBR $56,878,000.00
  • SQNS $37,325,000.00
  • Revenue This Year
  • CSBR $9.30
  • SQNS N/A
  • Revenue Next Year
  • CSBR $31.17
  • SQNS $89.05
  • P/E Ratio
  • CSBR $29.53
  • SQNS $0.53
  • Revenue Growth
  • CSBR 10.11
  • SQNS 32.07
  • 52 Week Low
  • CSBR $3.75
  • SQNS $7.30
  • 52 Week High
  • CSBR $11.99
  • SQNS $58.30
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 46.30
  • SQNS 46.55
  • Support Level
  • CSBR $6.27
  • SQNS $9.40
  • Resistance Level
  • CSBR $6.90
  • SQNS $10.00
  • Average True Range (ATR)
  • CSBR 0.29
  • SQNS 0.58
  • MACD
  • CSBR -0.02
  • SQNS 0.23
  • Stochastic Oscillator
  • CSBR 23.37
  • SQNS 44.76

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: